Singapore markets open in 8 hours 16 minutes
Straits Times Index
3,303.19 +10.26 (+0.31%) S&P 500
5,158.26 +30.47 (+0.59%) Dow
38,736.81 +61.13 (+0.16%) Nasdaq
16,268.90 +112.57 (+0.70%) Bitcoin USD
63,465.25 -920.01 (-1.43%) CMC Crypto 200
1,368.80 +56.17 (+4.28%)
Ascendis Pharma A/S (ASND)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:40PM EDT. Market open.
| Previous close | 137.20 |
| Open | 138.36 |
| Bid | 133.31 x 100 |
| Ask | 134.69 x 100 |
| Day's range | 133.53 - 138.36 |
| 52-week range | 83.75 - 161.00 |
| Volume | |
| Avg. volume | 335,876 |
| Market cap | 7.574B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Ascendis Pharma A/S (NASDAQ:ASND) Q1 2024 Earnings Call Transcript
Ascendis Pharma A/S (NASDAQ:ASND) Q1 2024 Earnings Call Transcript May 4, 2024 Ascendis Pharma A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Q1 2024 Ascendis Pharma Earnings Conference Call. At this time, all […]
- Simply Wall St.
Ascendis Pharma First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Ascendis Pharma ( NASDAQ:ASND ) First Quarter 2024 Results Key Financial Results Revenue: €95.9m (up 186% from 1Q...
- Zacks
Why Earnings Season Could Be Great for Ascendis Pharma (ASND)
Ascendis Pharma (ASND) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
© 2024 Yahoo. All rights reserved.